Breaking News Instant updates and real-time market news.

AMD

AMD

$19.09

-0.49 (-2.50%)

, INTC

Intel

$50.14

0.2 (0.40%)

05:03
08/10/18
08/10
05:03
08/10/18
05:03

AMD upgraded to Neutral from Sell at Goldman Sachs

Goldman Sachs analyst Toshiya Hari upgraded AMD (AMD) to Neutral from Sell and raised his price target for the shares to $21 from $13.25. The chipmaker closed yesterday down 48c to $19.10. Intel's (INTC) struggles with 10nm process technology make it increasingly harder to argue for a bear thesis, even following the recent rally in the shares, Hari tells investors in a research note. The analyst admits, however, that he still has concerns related to AMD's graphics processing unit business given the continued decline in cryptocurrency mining demand and increased competition from Nvidia (NVDA). Nevertheless, the delay in Intel's new products will allow AMD to gain share in not only client computer processing units, but also in the "lucrative" server CPU market, Hari contends. He believes this makes for a balanced risk/reward profile on AMD shares.

AMD

AMD

$19.09

-0.49 (-2.50%)

INTC

Intel

$50.14

0.2 (0.40%)

NVDA

Nvidia

$256.40

-2 (-0.77%)

  • 14

    Aug

  • 16

    Aug

  • 16

    Aug

  • 28

    Aug

  • 12

    Sep

AMD AMD
$19.09

-0.49 (-2.50%)

08/06/18
BOFA
08/06/18
NO CHANGE
Target $25
BOFA
Buy
AMD price target raised to $25 from $21 at BofA/Merrill
BofA/Merrill analyst Vivek Arya raised his price target on AMD (AMD) to $25 and kept his Buy rating while also raising his FY19 EPS target to 75c vs. consensus view of 62c. The analyst cites AMD's "generational opportunity" to exploit Intel (INTC) 10nm delays to gain market share data security and cloud servers along with its recent upward revision in server average selling prices, as indicated by Mercury industry data. Arya further notes the company's "discussion with several large cloud customers for its second-gen 7nm Rome server, as well as its 7nm computing graphics card for AI, where it competes against NVidia (NVDA).
08/06/18
LEHM
08/06/18
NO CHANGE
Target $15
LEHM
Underweight
AMD price target raised to $15 from $9 at Barclays
Barclays analyst Blayne Curtis raised his price target for (AMD) to $15 from $9 but keeps an Underweight rating on the name. The stock closed Friday down 30c to $18.49. The analyst this morning also downgraded his rating on Intel (INTC) to Equal Weight from Overweight. Curtis is now using a higher multiple for AMD to reflect a wider range of outcomes for traction of its Epyc server. The analyst, however, says he has not seen any evidence to support these more bullish levels. Clearly the market is much more optimistic on AMD's growth prospects as reflected in the stock's appreciation, Curtis tells investors in a research note. AMD has effectively reduced the discussion of future server performance to process technology but the lack of response from Intel following the multiple 10nm push-outs leaves little reason for investors to believe differently, Curtis writes.
07/30/18
COWN
07/30/18
NO CHANGE
Target $25
COWN
Outperform
AMD price target raised to $25 following management meetings at Cowen
Cowen analyst Matthew Ramsay raised his price target on AMD to $25 from $21 following meetings with management. The analyst noted the company posted strong Q2 results, but management's message was the company was just getting started. He said management is determined to capitalize on share gain opportunities in datacenter and client markets. Ramsay reiterated his Outperform rating on AMD shares.
07/27/18
JEFF
07/27/18
NO CHANGE
Target $44
JEFF
Underperform
Intel model 'showing signs of stress' despite beat, says Jefferies
While Intel (INTC) last night "beat and raised handily" for the second quarter in a row, the model is "showing signs of stress," Jefferies analyst Mark Lipacis tells investors in a post-earnings research note. The analyst highlights declining gross margins, free cash flow well below earnings, and Increasing competition from Nvidia (NVDA), AMD (AMD) "and perhaps even its own customers." Delays in Intel's 10nm product ramp and process node transitions may translate to a disadvantage to AMD in servers in the second half of 2019, Lipacis contends. He reiterates an Underperform rating on Intel and bumped up his price target for the shares to $44 from $42.
INTC Intel
$50.14

0.2 (0.40%)

08/09/18
MSCO
08/09/18
NO CHANGE
MSCO
Morgan Stanley downgrades semiconductor industry view to Cautious
Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore keeps Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. Other semiconductor names include Microchip (MCHP), Qorvo (QRVO), Micron (MU), Intel (INTC), Broadcom (AVGO) and Qualcomm (QCOM).
08/08/18
CHLM
08/08/18
NO CHANGE
Target $28
CHLM
Sell
Applied Optoelectronics price target raised to $28 from $20 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Applied Optoelectronics (AAOI) to $28 from $20 following a "strong" Q2 result, driven by strong upside from Data Center, specifically Facebook (FB). The analyst thinks most of the upside was from lack of supply from a competitor he believes to be Intel (INTC). He reiterates a Sell rating on Applied Optoelectronics shares.
08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.
08/06/18
08/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis saying he believes upside in the shares will be challenging until the company's margins bottom. 2. Immune Pharmaceuticals (IMNP) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's delisting from Nasdaq and evaluation of strategic options as it seeks to resolve its financing overhang. 3. Flowers Foods (FLO) downgraded to Equal Weight from Overweight at Consumer Edge. 4. CommScope (COMM) downgraded to Hold from Buy at Jefferies with analyst George Notter saying after "further reflection" from the earnings call and conversations with industry contacts, he believes CommScope's Mobility division performance will not improve this year or next. 5. Acadia (ACAD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Danielle Brill saying the recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NVDA Nvidia
$256.40

-2 (-0.77%)

08/09/18
08/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS SEAGATE TO SELL: Goldman Sachs analyst Mark Delaney downgraded Seagate Technology (STX) to Sell from Neutral and lowered his price target for the shares to $44 from $50, representing 20% downside from current levels. While Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market," Delaney said. He believes Seagate's fundamentals will peak in the second half of 2018 and decline in 2019. RBC CUTS FOX TO SECTOR PERFORM ON VALUATION: RBC Capital analyst Steven Cahall downgraded 21st Century Fox (FOXA) to Sector Perform from Outperform, but raised his price target to $49 from $45. The analyst noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. Cahall adds that while the company is "undervalued", he awaits the separation to re-evaluate his stance. MORGAN STANLEY DOWNGRADES SEMI INDUSTRY: Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore kept Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. SOUTHERN COMPANY GETS MULTIPLE DOWNGRADES AFTER Q2 REPORT: Barclays analyst Eric Beaumont downgraded Southern Company (SO) to Equal Weight and lowered his price target for the shares to $48 from $51. Credit Suisse analyst Michael Weinstein downgraded Southern Company to Underperform from Neutral and lowered his price target on the shares to $43 from $46. Guggenheim analyst Shahriar Pourreza downgraded Southern Company to Neutral from Buy and lowered his price target on the stock to $47 from $50. Evercore ISI analyst Greg Gordon downgraded Southern Company to Underperform from In Line and lowered his price target on Southern shares to $46 from $46.75.
08/07/18
08/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS ZILLOW TO NEUTRAL: BofA Merrill Lynch analyst Nat Schindler downgraded Zillow (Z, ZG) to Neutral from Buy and cut its price target to $60 from $70 following the Q2 report and reduction in guidance. Schindler said the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook was cut, and other revenue also missed, indicating the new construction opportunity is also taking longer to materialize. Zillow Class A shares are down about 17% in late morning trading. MORGAN STANLEY SAYS WAYMO COULD BE WORTH $175B: Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's (GOOG, GOOGL) Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares. GOLDMAN RAISES NVIDIA TARGET AHEAD OF EARNINGS: Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat Street estimates and raised guidance, the analyst expects a "noisy" quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining, and potential disruption from the virus attack at TSMC (TSM). That said, Hari noted that his long-term bull thesis on Nvidia remains intact and reiterated a Buy rating on the shares. ARGUS CUTS CBS TO HOLD: Argus analyst Joseph Bonner downgraded CBS (CBS) to Hold from Buy, noting significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIA, VIAB) merger. Bonner noted that if the Moonves allegations are proven true, he would be immediately dismissed, which could end the board's bid to remain independent and thereby inflict damage on the shareholders.
08/07/18
GSCO
08/07/18
NO CHANGE
Target $324
GSCO
Buy
Nvidia price target raised to $324 from $310 at Goldman Sachs
Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat/raised Street estimates, the analyst expects a noisy quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining and the potential side-effects in the core Gaming GPU business, and potential disruption from the virus attack at TSMC (TSM). That said, Hari notes that his long-term bull thesis on Nvidia remains intact and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

TCMD

Tactile Systems

$64.09

2.08 (3.35%)

05:15
01/24/19
01/24
05:15
01/24/19
05:15
Recommendations
Tactile Systems analyst commentary  »

Piper more bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIA

Acacia Communications

$42.07

0.93 (2.26%)

05:12
01/24/19
01/24
05:12
01/24/19
05:12
Recommendations
Acacia Communications analyst commentary  »

Acacia Q4 results to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

GKOS

Glaukos

$60.73

-0.42 (-0.69%)

, AGN

Allergan

$160.81

3.045 (1.93%)

05:09
01/24/19
01/24
05:09
01/24/19
05:09
Recommendations
Glaukos, Allergan analyst commentary  »

Piper values Glaukos…

GKOS

Glaukos

$60.73

-0.42 (-0.69%)

AGN

Allergan

$160.81

3.045 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 18

    May

  • 28

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.42

0.37 (0.14%)

05:05
01/24/19
01/24
05:05
01/24/19
05:05
General news
President Trump delays State of the Union address due to shutdown »

President Trump said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.42

0.37 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$52.25

-0.25 (-0.48%)

05:01
01/24/19
01/24
05:01
01/24/19
05:01
Downgrade
Weibo rating change  »

Weibo downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

05:00
01/24/19
01/24
05:00
01/24/19
05:00
Downgrade
Reckitt Benckiser rating change  »

Reckitt Benckiser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ANIX

Anixa Biosciences

$4.52

0.11 (2.49%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Anixa Biosciences to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Stephens restaurants analyst to hold a luncheon »

Restaurants Analyst…

TXMD

TherapeuticsMD

$5.10

-0.045 (-0.88%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
TherapeuticsMD management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SAIC

SAIC

$64.26

-1.21 (-1.85%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
SAIC management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Kansas City Fed Manufacturing Index Level to be reported at 11:00 »

January Kansas City Fed…

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 1/19 Jobless…

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Breaking General news story  »

Week of 1/18 EIA Natural…

SMTX

SMTC Corp.

$5.57

0.14 (2.58%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
SMTC Corp. management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SSP

E.W. Scripps

$18.51

0.42 (2.32%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
E.W. Scripps management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FB

Facebook

$144.35

-3.45 (-2.33%)

, SNAP

Snap

$5.98

0.06 (1.01%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Tech & Internet…

FB

Facebook

$144.35

-3.45 (-2.33%)

SNAP

Snap

$5.98

0.06 (1.01%)

TWTR

Twitter

$30.97

-1.29 (-4.00%)

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 04

    Feb

  • 05

    Feb

  • 07

    Feb

  • 25

    Feb

  • 03

    Mar

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Breaking General news story  »

Week of 1/18 EIA…

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
UBS services analyst to hold an analyst/industry conference call »

Services Analyst Lasser…

FOMX

Foamix

$3.77

0.09 (2.45%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Foamix to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Leading Indicators to be reported at 10:00 »

December Leading…

NOG

Northern Oil and Gas

$2.64

(0.00%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Northern Oil and Gas management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

INSE

Inspired Entertainment

$5.91

(0.00%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Inspired Entertainment management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Breaking General news story  »

Week of 1/22 4-Week Bill…

04:55
01/24/19
01/24
04:55
01/24/19
04:55
General news
Breaking General news story  »

Week of 1/23 Fed Balance…

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Stephens building materials analyst to hold group luncheon »

Building Materials…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.